1. Home
  2. CRBU vs INSG Comparison

CRBU vs INSG Comparison

Compare CRBU & INSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.68

Market Cap

167.6M

Sector

Health Care

ML Signal

HOLD

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$9.79

Market Cap

190.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBU
INSG
Founded
2011
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
167.6M
190.1M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
CRBU
INSG
Price
$1.68
$9.79
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$10.75
$15.33
AVG Volume (30 Days)
1.8M
385.2K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
3.64
N/A
EPS
N/A
0.65
Revenue
N/A
$313,832,000.00
Revenue This Year
$1.63
$16.21
Revenue Next Year
$10.93
$13.28
P/E Ratio
N/A
$15.31
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$6.28
52 Week High
$3.53
$21.90

Technical Indicators

Market Signals
Indicator
CRBU
INSG
Relative Strength Index (RSI) 40.66 33.95
Support Level $1.39 $9.80
Resistance Level $1.73 $11.81
Average True Range (ATR) 0.13 0.66
MACD -0.01 -0.03
Stochastic Oscillator 28.05 10.53

Price Performance

Historical Comparison
CRBU
INSG

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

Share on Social Networks: